Lionel Leventhal

Mr. Leventhal developed the area of royalty and synthetic royalty financing (aka "Revenue Interest Financing") for the biopharma, medical device and diagnostics sectors as a co-founder and general partner of Paul Capital Healthcare, the first fund established for the purchase and financing of healthcare royalty and revenue interests. Subsequent to his 13 years co-managing Paul Capital Healthcare as a principal investor, as a banker, he has demonstrated consistent best-in-class execution for royalty monetizations and revenue interest financings in terms of transaction size, cost of capital, structures to maximize retained upside, and absence of financial covenants and restrictive operating covenants. Prior to joining Ladenburg Thalmann, he served as a Managing Director and Head of Royalty & Revenue Interest Financing at Houlihan Lokey and is the Managing Member of the merchant bank Royalty/Revenue Interest Capital, LLC. Mr. Leventhal was graduated Magna Cum Laude with an A.B. degree in Economics from Harvard College, and received his MBA with honors and distinction from Harvard Business School. He is a director of Art Medical Ltd., and is the Board Chair of The Children's Brain Tumor Foundation.